Kad\u0131nlarda BRCA1 ve BRCA2 Gen Mutasyonlar\u0131nda Bilateral Salpingo-ooforektomi Sonras\u0131 Uzun D\u00f6nem Sa\u011fkal\u0131m Bulgular\u0131<\/p>\n
BRCA1 ve BRCA2 genlerinde patojenik varyant ta\u015f\u0131yan ve daha \u00f6nce meme kanseri tan\u0131s\u0131 alm\u0131\u015f kad\u0131nlarda bilateral salpingo-ooforektominin (BSO) uzun vadeli etkilerini inceleyen yeni bir retrospektif kohort \u00e7al\u0131\u015fmas\u0131, meme kanseri sonras\u0131 ya\u015fam s\u00fcresinin anlaml\u0131 \u015fekilde uzad\u0131\u011f\u0131n\u0131 ortaya koydu. University of Cambridge\u2019den ara\u015ft\u0131rmac\u0131lar\u0131n, \u0130ngiltere Ulusal Sa\u011fl\u0131k Servisi (NHS) b\u00fcnyesindeki Ulusal Hastal\u0131k Kay\u0131t Servisi (NDRS) veritaban\u0131ndan yararlanarak yapt\u0131\u011f\u0131 bu \u00e7al\u0131\u015fma, BSO i\u015fleminin sadece yumurtal\u0131k kanseri riskini azaltmakla kalmay\u0131p, ayn\u0131 zamanda t\u00fcm nedenlere ba\u011fl\u0131 mortaliteyi \u00f6nemli \u00f6l\u00e7\u00fcde d\u00fc\u015f\u00fcrd\u00fc\u011f\u00fcn\u00fc g\u00f6sterdi. Bu bulgular, BRCA mutasyonlu hastalar i\u00e7in klinik karar alma s\u00fcre\u00e7lerinde \u00f6nemli bir d\u00f6n\u00fcm noktas\u0131 te\u015fkil ediyor.<\/p>\n
BRCA1 ve BRCA2 gen mutasyonlar\u0131, kad\u0131nlarda hem meme hem yumurtal\u0131k kanseri riskinin ciddi \u015fekilde artmas\u0131na neden olarak, hastalar\u0131n erken ya\u015flarda \u00f6nleyici tedbirler almas\u0131n\u0131 gerektirir. G\u00fcn\u00fcm\u00fczde klinik rehberlikler, BRCA1 ta\u015f\u0131y\u0131c\u0131lar\u0131 i\u00e7in yumurtal\u0131k ve t\u00fcplerin 35-40 ya\u015flar\u0131 aras\u0131nda, BRCA2 ta\u015f\u0131y\u0131c\u0131lar\u0131 i\u00e7in ise 40-45 ya\u015flar\u0131 aras\u0131nda cerrahi olarak \u00e7\u0131kar\u0131lmas\u0131n\u0131 \u00f6neriyor. Bu cerrahi uygulama, yumurtal\u0131k kanseri geli\u015fme riskini yakla\u015f\u0131k y\u00fczde 80 oran\u0131nda azaltmas\u0131yla bilinirken, meme kanseri tan\u0131s\u0131 olan hastalar s\u00f6z konusu oldu\u011funda uzun d\u00f6nem mortalite \u00fczerindeki etkileri s\u0131n\u0131rl\u0131 bilgiyle s\u00fcrd\u00fcr\u00fclmekteydi.<\/p>\n
Cerrahi menopoz olarak adland\u0131r\u0131lan bu i\u015flemin ard\u0131ndan v\u00fccutta aniden \u00f6strojen \u00fcretiminin durmas\u0131, metabolik, kardiyovask\u00fcler ve psikolojik baz\u0131 de\u011fi\u015fikliklerin ortaya \u00e7\u0131kmas\u0131na yol a\u00e7abiliyor. Ayr\u0131ca, meme kanseri ge\u00e7irmi\u015f hastalarda hormon replasman tedavisinin uygulanmas\u0131 kanserin hormon duyarl\u0131 n\u00fcks riskini art\u0131rabilece\u011fi i\u00e7in genellikle \u00f6nerilmemektedir. Dolay\u0131s\u0131yla, BSO\u2019nun genel fayda-zarar dengesi, \u00f6zellikle BRCA mutasyon ta\u015f\u0131yan ve meme kanseri tedavisi g\u00f6rm\u00fc\u015f kad\u0131nlarda netle\u015fmemi\u015fti.<\/p>\n
Bu kar\u0131\u015f\u0131kl\u0131\u011f\u0131 gidermek ad\u0131na Cambridge ara\u015ft\u0131rmac\u0131lar\u0131, b\u00fcy\u00fck veri analizine odakland\u0131. Yakla\u015f\u0131k 3.400 BRCA1 veya BRCA2 patojenik varyant ta\u015f\u0131yan ve meme kanseri ge\u00e7mi\u015fi olan kad\u0131nlar\u0131n sa\u011fl\u0131k kay\u0131tlar\u0131n\u0131, genetik test sonu\u00e7lar\u0131 ve klinik verilerle birle\u015ftirerek geriye d\u00f6n\u00fck bir kohort olu\u015fturdu. Bunlardan yakla\u015f\u0131k 1.850\u2019sinin BSO ameliyat\u0131 ge\u00e7irmi\u015f olmas\u0131, operasyon ge\u00e7iren ve ge\u00e7irmeyen gruplar aras\u0131nda kapsaml\u0131 kar\u015f\u0131la\u015ft\u0131rmal\u0131 analiz yap\u0131lmas\u0131na olanak sa\u011flad\u0131. Ortalama be\u015f y\u0131l\u0131n \u00fczerindeki takip s\u00fcrecinde elde edilen veriler, cerrahinin uzun d\u00f6nem etkileri \u00fczerine derinlemesine i\u00e7g\u00f6r\u00fcler sundu.<\/p>\n
\u00c7al\u0131\u015fman\u0131n istatistiksel sonu\u00e7lar\u0131, BSO ge\u00e7iren kad\u0131nlar\u0131n t\u00fcm nedenlere ba\u011fl\u0131 mortalite riskini yar\u0131 yar\u0131ya azaltt\u0131\u011f\u0131n\u0131 g\u00f6sterdi. BRCA2 mutasyonlu hastalarda bu azalma y\u00fczde 56, BRCA1 mutasyonlu hastalarda ise y\u00fczde 38 olarak kaydedildi. Mortalite avantaj\u0131n\u0131n yan\u0131nda, cerrahinin ikincil kanserlerin g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131n\u0131 yakla\u015f\u0131k y\u00fczde 40 d\u00fc\u015f\u00fcrd\u00fc\u011f\u00fc g\u00f6r\u00fcld\u00fc. \u00d6zellikle meme kanseri ge\u00e7irmi\u015f hastalar i\u00e7in bu sonu\u00e7lar, cerrahinin sadece yumurtal\u0131k kanseri de\u011fil, genel kanser riski \u00fczerinde de koruyucu etkisini i\u015faret ediyor.<\/p>\n
Uzun d\u00f6nem yan etkiler a\u00e7\u0131s\u0131ndan endi\u015fe edilen kardiyovask\u00fcler hastal\u0131k, inme ve depresyon insidans\u0131 ise BSO grubunda anlaml\u0131 art\u0131\u015f g\u00f6stermedi. Genel n\u00fcfusta erken ooforektomi sonras\u0131 kardiyovask\u00fcler risklerin y\u00fckseldi\u011fine dair \u00e7e\u015fitli \u00e7al\u0131\u015fmalar olsa da bu \u00f6zel hasta grubu i\u00e7in risk art\u0131\u015f\u0131 kaydedilmedi. Ayr\u0131ca mental sa\u011fl\u0131k parametrelerinde bir bozulma g\u00f6zlenmemesi, menopozun cerrahi olarak ind\u00fcklenmesinin psikolojik a\u00e7\u0131dan da olduk\u00e7a tolere edilebilir oldu\u011funu g\u00f6sterdi.<\/p>\n
Ara\u015ft\u0131rman\u0131n lideri Hend Hassan, BSO\u2019nun sa\u011fkal\u0131mda sa\u011flad\u0131\u011f\u0131 bariz faydalar\u0131n, hastalar\u0131n ve klinisyenlerin cerrahi menopozun potansiyel olumsuz etkilerine dair ta\u015f\u0131d\u0131\u011f\u0131 endi\u015feleri \u00f6nemli \u00f6l\u00e7\u00fcde hafifletti\u011fini belirtti. Bu netlik, y\u00fcksek risk grubundaki kad\u0131nlarla sa\u011fl\u0131k profesyonellerinin daha bilin\u00e7li tedavi ve \u00f6nleyici yakla\u015f\u0131mlar belirlemesine olanak sa\u011fl\u0131yor.<\/p>\n
\u00c7al\u0131\u015fmada ayr\u0131ca sosyal ve demografik fakt\u00f6rlerle ilgili dikkat \u00e7ekici e\u015fitsizlikler rapor edildi. Beyaz kad\u0131nlar\u0131n BSO cerrahisi ge\u00e7irme olas\u0131l\u0131\u011f\u0131, siyahi ve Asyal\u0131 kad\u0131nlardan kat kat y\u00fcksek bulunurken, sosyoekonomik d\u00fczeyi y\u00fcksek b\u00f6lgelerde ya\u015fayan kad\u0131nlar\u0131n da operasyon alma oran\u0131 daha fazla \u00e7\u0131kt\u0131. Bu durum, sa\u011fl\u0131k sisteminde var olan eri\u015fim, fark\u0131ndal\u0131k ve karar alma s\u00fcre\u00e7lerindeki engellerin en aza indirilmesi i\u00e7in kapsaml\u0131 politikalar\u0131n gereklili\u011fini ortaya koyuyor.<\/p>\n
Cambridge \u00dcniversitesi\u2019nden senior ara\u015ft\u0131rmac\u0131 Antonis Antoniou, \u00e7al\u0131\u015fmalar\u0131n klinik rehberleri ve hasta bilgilendirmelerini k\u00f6kl\u00fc bi\u00e7imde de\u011fi\u015ftirece\u011fini vurgulad\u0131. BSO\u2019nun ya\u015fama ve kanser sonras\u0131 sa\u011fkal\u0131ma ili\u015fkin g\u00fc\u00e7l\u00fc etkilerinin bilimsel dayana\u011f\u0131n\u0131n ortaya \u00e7\u0131kmas\u0131, bu prosed\u00fcr\u00fcn uygun hastalarda daha yayg\u0131n ve erken \u00f6nerilmesini te\u015fvik edecek. Ayr\u0131ca, NHS\u2019nin entegre veri kaynaklar\u0131n\u0131n kullan\u0131lmas\u0131, benzer y\u00fcksek riskli pop\u00fclasyonlarda b\u00fcy\u00fck \u00f6l\u00e7ekli, ger\u00e7e\u011fe dayal\u0131 kan\u0131tlara ula\u015fmada model te\u015fkil ediyor.<\/p>\n
Bu ara\u015ft\u0131rman\u0131n y\u00f6ntemsel ba\u015far\u0131s\u0131, randomize kontroll\u00fc \u00e7al\u0131\u015fmalarda etik zorluklar nedeniyle ger\u00e7ekle\u015ftirilemeyen kritik sorular\u0131 b\u00fcy\u00fck veri ve elektronik sa\u011fl\u0131k kay\u0131tlar\u0131n\u0131 birle\u015ftirerek yan\u0131tlam\u0131\u015f oldu. Bu yakla\u015f\u0131m, onkoloji ba\u015fta olmak \u00fczere bir\u00e7ok alanda bireyselle\u015ftirilmi\u015f \u00f6nleyici ve tedavi stratejilerinin geli\u015ftirilmesini h\u0131zland\u0131racak yeni bir bilimsel paradigmay\u0131 temsil ediyor.<\/p>\n
Temel olarak Cancer Research UK\u2019nin finanman deste\u011fiyle y\u00fcr\u00fct\u00fclen ve NIHR Cambridge Biyomedikal Ara\u015ft\u0131rma Merkezi\u2019nin kritik katk\u0131s\u0131yla ger\u00e7ekle\u015fen bu \u00e7al\u0131\u015fma, Cambridge Kanser Ara\u015ft\u0131rma Hastanesi i\u015f birli\u011fiyle y\u00fcr\u00fct\u00fclen translasyonel ara\u015ft\u0131rmalarda da \u00f6nemli bir mihenk ta\u015f\u0131 niteli\u011finde. Bilimsel geli\u015fmeler ile hasta bak\u0131m\u0131n\u0131n yak\u0131n entegrasyonuna y\u00f6nelik \u00e7abalar, y\u00fcksek riskli genetik grup kad\u0131nlar\u0131n ya\u015fam kalitesini art\u0131rmay\u0131 hedefliyor.<\/p>\n
Sonu\u00e7ta, BRCA1 ve BRCA2 mutasyonlu kad\u0131nlarda meme kanseri ge\u00e7mi\u015fi olan hastalara bilateral salpingo-ooforektominin \u00f6nerilmesi, yaln\u0131zca yumurtal\u0131k kanseri riskini de\u011fil, genel mortaliteyi de azaltt\u0131\u011f\u0131n\u0131, ayn\u0131 zamanda cerrahi menopozun kardiyovask\u00fcler ve mental sa\u011fl\u0131k a\u00e7\u0131s\u0131ndan tolere edilebilir oldu\u011funu kesin bi\u00e7imde ortaya koyuyor. Klinik uygulamada bu bilgiler \u0131\u015f\u0131\u011f\u0131nda e\u015fitsizliklerin azalt\u0131lmas\u0131 ve daha fazla kad\u0131n\u0131n bu ya\u015fam kurtar\u0131c\u0131 prosed\u00fcrden faydalanmas\u0131 \u00f6ncelik haline gelecek.<\/p>\n
Bu \u00f6nemli ke\u015fifler, BRCA mutasyonlu kad\u0131nlar\u0131n sa\u011fl\u0131k yolculu\u011funda cerrahi m\u00fcdahalenin de\u011ferini yeniden tan\u0131mlarken, toplumsal sa\u011fl\u0131k politikalar\u0131n\u0131n geli\u015ftirilmesine de ilham veriyor. Ara\u015ft\u0131rma sonu\u00e7lar\u0131, hastalar\u0131n bilin\u00e7lendirilmesi, sa\u011fl\u0131k hizmetlerine eri\u015fimlerin iyile\u015ftirilmesi ve risk azalt\u0131c\u0131 \u00f6nerilerin yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131 i\u00e7in etkin bir temel olu\u015fturacak. Kanser alan\u0131ndaki ki\u015fiye \u00f6zel yakla\u015f\u0131mlar sayesinde, y\u00fcksek riskli topluluklarda d\u00fcnya \u00e7ap\u0131nda ya\u015fam s\u00fcresi ve kalitesi artacak.<\/p>\n
—<\/p>\n
Ara\u015ft\u0131rma Konusu<\/strong>: People Kad\u0131nlarda BRCA1 ve BRCA2 Gen Mutasyonlar\u0131nda Bilateral Salpingo-ooforektomi Sonras\u0131 Uzun D\u00f6nem Sa\u011fkal\u0131m Bulgular\u0131 BRCA1 ve BRCA2 genlerinde patojenik varyant ta\u015f\u0131yan ve daha \u00f6nce meme kanseri tan\u0131s\u0131 alm\u0131\u015f kad\u0131nlarda bilateral salpingo-ooforektominin (BSO) uzun vadeli etkilerini inceleyen yeni bir retrospektif kohort \u00e7al\u0131\u015fmas\u0131, meme kanseri sonras\u0131 ya\u015fam s\u00fcresinin anlaml\u0131 \u015fekilde uzad\u0131\u011f\u0131n\u0131 ortaya koydu. University of Cambridge\u2019den ara\u015ft\u0131rmac\u0131lar\u0131n, \u0130ngiltere…<\/p>\n","protected":false},"author":1,"featured_media":5094,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[28],"tags":[6139,6138,6142,6140,6141],"tmauthors":[],"class_list":{"0":"post-5093","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-kanser","8":"tag-bilateral-salpingo-ooforektomi-uzun-donem-sagkalim","9":"tag-brca-mutasyonlu-meme-kanseri-tedavisi","10":"tag-brca-tasiyicilarinda-cerrahi-menopoz-etkileri","11":"tag-brca1-ve-brca2-gen-mutasyonlari-risk-yonetimi","12":"tag-meme-kanseri-sonrasi-erken-mortalite-azaltimi"},"jetpack_featured_media_url":"https:\/\/haber360.com\/wp-content\/uploads\/2025\/05\/BRCA-Mutasyonlu-Meme-Kanserinde-Ooforektomi-ve-Salpenjektominin-Erken-Mortalite-Azaltimi-1746662368.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5093","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/comments?post=5093"}],"version-history":[{"count":0,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/posts\/5093\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media\/5094"}],"wp:attachment":[{"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/media?parent=5093"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/categories?post=5093"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tags?post=5093"},{"taxonomy":"tmauthors","embeddable":true,"href":"https:\/\/haber360.com\/index.php\/wp-json\/wp\/v2\/tmauthors?post=5093"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMakale Ba\u015fl\u0131\u011f\u0131<\/strong>: Long-term health outcomes of bilateral salpingo-oophorectomy in BRCA1 and BRCA2 pathogenic variant carriers with personal history of breast cancer: a retrospective cohort study using linked electronic health records
\nHaberin Yay\u0131n Tarihi<\/strong>: 8-May-2025
\nWeb References<\/strong>:
\nhttps:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(25)00156-1\/fulltext
\nhttp:\/\/dx.doi.org\/10.1016\/S1470-2045(25)00156-1
\nDoi Referans<\/strong>: 10.1016\/S1470-2045(25)00156-1
\nAnahtar Kelimeler<\/strong>: Cancer, Breast cancer, Ovarian cancer, BRCA1 and BRCA2 gene mutations, clinical guidelines for BRCA mutation management, early mortality risk reduction in breast cancer, electronic health records in cancer research, impact of BSO on all-cause mortality, long-term health outcomes after BSO, oophorectomy benefits for BRCA mutation carriers, ovarian cancer risk management strategies, preventative interventions for high-risk women, retrospective cohort study on cancer surgeries, risk-reducing surgeries for cancer prevention, salpingectomy and breast cancer survival<\/p>\n","protected":false},"excerpt":{"rendered":"